Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort Study

OBJECTIVE: To compare changes in bone mineral density (BMD) in rheumatoid arthritis (RA) patients receiving three-year conventional synthetic disease-modifying anti-rheumatic drugs (csDMARD), tumor necrosis factor-α inhibitors (TNFi), and abatacept. METHODS: Patients with RA were recruited from Sept...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ming-Han, Yu, Shan-Fu, Chen, Jia-Feng, Chen, Wei-Sheng, Liou, The-Ling, Chou, Chung-Tei, Hsu, Chung-Yuan, Lai, Han-Ming, Chen, Ying-Chou, Tsai, Chang-Youh, Cheng, Tien-Tsai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720866/
https://www.ncbi.nlm.nih.gov/pubmed/34987510
http://dx.doi.org/10.3389/fimmu.2021.783030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720866/
https://www.ncbi.nlm.nih.gov/pubmed/34987510
http://dx.doi.org/10.3389/fimmu.2021.783030

Ejemplares similares